Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-EACR: Preclinical models for developing combination therapeutics

The Achilles heel of acquired drug resistance

Date

08 Sep 2017

Session

ESMO-EACR: Preclinical models for developing combination therapeutics

Topics

Cytotoxic Therapy;  Translational Research

Presenters

Rene Bernards

Authors

R. Bernards

Author affiliations

  • -, Netherlands Cancer Institute, 000 - Amsterdam/NL
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.